An Open-Label Study to Investigate the AMPAɣ8 Receptor Occupancy of JNJ-64140284 With the Newly Developed TARP-γ8 PET Tracer [18F]JNJ-64511070 in Healthy Men
Phase of Trial: Phase I
Latest Information Update: 22 Mar 2019
Price : $35 *
At a glance
- Drugs JNJ-64140284 (Primary)
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 14 Mar 2019 Status changed from recruiting to completed.
- 05 Nov 2018 Status changed from not yet recruiting to recruiting.
- 09 Oct 2018 New trial record